• Korean journal of aerospace and environmental medicine
• /
• v.29 no.3
• /
• pp.96-100
• /
• 2019

The present study analyzed all of exotic malaria (EM) cases reported in the Republic of Korea (Korea) and Japan from 2015 to 2017 to assess the trends of incidence overtime to review the risk factors for travelers visiting malaria-endemic countries. We investigated 162 cases of EM in Korea with a cumulative incidence rate (CIR) of 0.105 per 100,000 populations nationwide and the CIR of the oversea travelers was 0.238 per 100,000 travelers, respectively. During the same period in Japan, 152 cases of EM in nationwide with a CIR of 0.041 and in the oversea travelers with a CIR of 0.297 were observed. When compared, the CIR of EM in nationwide was much higher than that in Japan (P<0.01), but a CIR of imported by travelers in Korea was lower than that in Japan (P<0.01).

• Pediatric Infection and Vaccine
• /
• v.24 no.2
• /
• pp.117-122
• /
• 2017

Blackwater fever is a serious clinical syndrome manifested by acute intravascular hemolysis, fever, and the passage of black or red urine, which is classically associated with falciparum malaria and irregular administration of quinine. In Korea, Plasmodium vivax is the only endemic malaria circulating; a number of imported cases of falciparum malaria have been reported in patients following return from international travel to a malaria endemic area. Therefore, it is important for health care professionals including pediatricians to be aware of the falciparum malaria and its clinical courses. Herein, we report a case of a 14-year-old girl with severe falciparum malaria that was complicated by blackwater fever.

• Parasites, Hosts and Diseases
• /
• v.36 no.2
• /
• pp.143-146
• /
• 1998

Resistance of Plcsmodium species to antimalarial agents has become increasingly challenging to the management and prevention of malaria. We experienced an imported case of tertian malaria due to Plasmodum viuax relapsed after a seemingly successful treatment with conventional course of hydroxychloroquine and primaquine. A 35-year-old man developed fever three days after return from India and mainland China. After his illness was diagnosed as tertian malaria, he was managed with hydroxy- chloroquine and then primaquine (primaquine base 15 mg/day for 14 days). Thereafter peripheral blood smears showed no malarial parasites, and there was no relapse of symptom until the 55th post-treatment day, however, six months after the above treatment tertian malaria relapsed. He was managed with the same medications again un malaria did not relapse for 10 months.